A head-to-head comparison of the measurement properties of EQ-5D-3L and EQ-5D-5L in Chinese family caregivers of cancer patients
- PMID: 38060009
- DOI: 10.1007/s00520-023-08231-2
A head-to-head comparison of the measurement properties of EQ-5D-3L and EQ-5D-5L in Chinese family caregivers of cancer patients
Abstract
Background: Although both EQ-5D-3L(3L) and EQ-5D-5L(5L) have demonstrated good measurement properties in several patient populations, there is currently limited evidence comparing the measurement properties of 3L and 5L in family caregivers (FCs) of cancer patients.
Purpose: This study aimed to compare the measurement properties of 3L and 5L in a sample of family caregivers of cancer patients.
Methods: A consecutive sample of FCs of cancer patients recruited from three tertiary hospitals were invited to complete the two versions of the EQ-5D in two rounds of interviews. We compared i) the ceiling effect using the McNemar's test, ii) test-retest reliability using intraclass correlation coefficient (ICC) and Cohen's Kappa, iii) convergent validity using Spearman's rank correlation coefficient, iv) known-group validity using F-statistic, v) and discriminant capacity using ordinal logistic regression.
Results: A total of 416 FCs completed the baseline questionnaire and 120 caregivers completed the follow-up questionnaire. Ceiling effects were smaller in 5L (12.5%) than in 3L (20.7%). The convergent validity (r = 0.344-0.771), known-groups validity (Fratio5L/3L = 2.06-4.09), discriminant capacity (ES = 0.341-0.396), and test-retest reliability (ICC = 0.725) of the 5L were slightly better than those of the 3L in China.
Conclusion: The current study found both 3L and 5L to be suitable for use by FCs of cancer patients. However, 5L showed superior measurement properties compared to 3L and therefore could be the preferred instrument when EQ-5D data of cancer patients FCs is required.
Keywords: Cancer; EQ-5D-3L; EQ-5D-5L; Family caregiver; Measurement property.
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
A head-to-head comparison of measurement properties of the EQ-5D-3L and EQ-5D-5L in acute myeloid leukemia patients.Qual Life Res. 2021 Mar;30(3):855-866. doi: 10.1007/s11136-020-02644-w. Epub 2020 Sep 23. Qual Life Res. 2021. PMID: 32965633
-
Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients.Health Qual Life Outcomes. 2015 Feb 6;13:14. doi: 10.1186/s12955-014-0203-3. Health Qual Life Outcomes. 2015. PMID: 25890017 Free PMC article.
-
Measurement Properties of the EQ-5D-5L and EQ-5D-3L in Six Commonly Diagnosed Cancers.Patient. 2021 Mar;14(2):209-222. doi: 10.1007/s40271-020-00466-z. Epub 2020 Oct 30. Patient. 2021. PMID: 33123985
-
Head-to-Head Comparisons of the Distributional Characteristics and Measurement Properties of the 3-Level and 5-Level Versions of the EQ-5D-Y: A Systematic Review.Value Health. 2025 Apr 15:S1098-3015(25)02303-4. doi: 10.1016/j.jval.2025.03.020. Online ahead of print. Value Health. 2025. PMID: 40246069 Review.
-
Measurement Properties of the EQ-5D-Y: A Systematic Review.Value Health. 2022 Nov;25(11):1910-1921. doi: 10.1016/j.jval.2022.05.013. Epub 2022 Jun 23. Value Health. 2022. PMID: 35752534 Review.
Cited by
-
The Psychometric Performance of Generic Preference-Based Measures in Informal Carers: A Systematic Review of Validation Studies.Pharmacoeconomics. 2025 Sep;43(9):1065-1082. doi: 10.1007/s40273-025-01509-9. Epub 2025 Jun 28. Pharmacoeconomics. 2025. PMID: 40580406
-
Mental health status and associated factors of caregivers of patients with malignant brain tumors.J Neurooncol. 2025 May;173(1):71-82. doi: 10.1007/s11060-025-04963-9. Epub 2025 Feb 7. J Neurooncol. 2025. PMID: 39918778 Free PMC article.
References
-
- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA A Cancer J Clin 71(3):209–249. https://doi.org/10.3322/caac.21660 - DOI
-
- International Agency for Research on Cancer. Global cancer observatory: cancer today. Available online: https://gco.iarc.fr/today/online-analysis-table . (accessed on 11 October 2022)
-
- Stewart BW, Wild CP (2014) World Cancer Report 2014. International Agency for Research on Cancer, France. http://www.esmo.org/Oncology-News/World-Cancer-Report-2014
-
- Li T, Chai P, Zhang Y, Wan Q, Zhai T, Guo F, Li Y, Wang R, Chen C, Liu G (2021) Analysis of Cost Accounting and Financing Burden of Tumor Treatment in China. Health Econ Res 38(07):17–20 in Chinese
-
- Huang HY, Shi JF, Guo LW, Bai YN, Liao XZ, Liu GX, Mao AY, Ren JS, Sun XJ, Zhu XY, Wang L, Song BB, Du LB, Zhu L, Gong JY, Zhou Q, Liu YQ, Cao R, Mai L, Lan L, Sun XH, Ren Y, Zhou JY, Wang YZ, Qi X, Lou PA, Shi D, Li N, Zhang K, He J, Dai M (2017) Expenditure and financial burden for the diagnosis and treatment of colorectal cancer in China: a hospital-based, multicenter, cross-sectional survey. Chin J Cancer 36(1):41. https://doi.org/10.1186/s40880-017-0209-4 - DOI - PubMed - PMC
MeSH terms
Grants and funding
- 72274045/National Natural Science Foundation of China
- 72274045/National Natural Science Foundation of China
- 72274045/National Natural Science Foundation of China
- 72274045/National Natural Science Foundation of China
- 72274045/National Natural Science Foundation of China
- 72274045/National Natural Science Foundation of China
- 72274045/National Natural Science Foundation of China
- 72274045/National Natural Science Foundation of China
- 72274045/National Natural Science Foundation of China
- 72274045/National Natural Science Foundation of China
- 72274045/National Natural Science Foundation of China
- 72274045/National Natural Science Foundation of China
- 72274045/National Natural Science Foundation of China
- 72274045/National Natural Science Foundation of China
- 72274045/National Natural Science Foundation of China
- CMB-19-308/China Medical Board
- CMB-19-308/China Medical Board
- CMB-19-308/China Medical Board
- CMB-19-308/China Medical Board
- CMB-19-308/China Medical Board
- CMB-19-308/China Medical Board
- CMB-19-308/China Medical Board
- CMB-19-308/China Medical Board
- CMB-19-308/China Medical Board
- CMB-19-308/China Medical Board
- CMB-19-308/China Medical Board
- CMB-19-308/China Medical Board
- CMB-19-308/China Medical Board
- CMB-19-308/China Medical Board
- CMB-19-308/China Medical Board
LinkOut - more resources
Full Text Sources
Medical